| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anti-lymphoma peptide is inspired by mapping a sequence of four amino acids of KRAI motif as nuclear localization signal of Crlz-1
|
Pi, Joo Hyun
|
|
|
33 |
1 |
p.
|
artikel
|
| 2 |
Attenuated titin protein expression is associated with advanced stages of ovarian cancer
|
Sharma, Harvey
|
|
|
33 |
1 |
p.
|
artikel
|
| 3 |
Bringing in cytokine support troops with an OV Trojan horse
|
Lee, Dean A.
|
|
|
33 |
1 |
p.
|
artikel
|
| 4 |
BTK inhibitors are a possible emerging therapeutic target for gastric cancer
|
Portillo-Miño, José Darío
|
|
|
33 |
1 |
p.
|
artikel
|
| 5 |
CAR-T cell therapy based on a TCR mimic nanobody targeting an intracellular antigen for solid cancers
|
Lin, Qingqing
|
|
|
33 |
1 |
p.
|
artikel
|
| 6 |
CD147-CAR-NK cell therapy shows minimal toxicities in human CD147 transgenic mouse model with solid tumors
|
Sabha, Youssef
|
|
|
33 |
1 |
p.
|
artikel
|
| 7 |
Cell-derived Newcastle disease virus variant with two amino acid substitutions near cleavage site of F shows favorable traits as oncolytic virus
|
Huberts, Marco
|
|
|
33 |
1 |
p.
|
artikel
|
| 8 |
circ-1584 selectively promotes the antitumor activity of the oncolytic virus M1 on pancreatic cancer
|
Hao, Taofang
|
|
|
33 |
1 |
p.
|
artikel
|
| 9 |
Combinatorial immunotherapy with anti-ROR1 CAR NK cells and an IL-21 secreting oncolytic virus against neuroblastoma
|
Chu, Yaya
|
|
|
33 |
1 |
p.
|
artikel
|
| 10 |
Cracking the code for more effective treatments for hepatocellular carcinomas: Promise and a path for immunovirotherapy
|
Lou, Emil
|
|
|
33 |
1 |
p.
|
artikel
|
| 11 |
Development of multivalent CAR T cells as dual immunotherapy and conditioning agents
|
Bubb, Quenton Rashawn
|
|
|
33 |
1 |
p.
|
artikel
|
| 12 |
Discovery and preclinical development of a SdAb-based CAR-T technology for targeting CD33 in AML
|
Bernasconi-Bisio, Franco
|
|
|
33 |
1 |
p.
|
artikel
|
| 13 |
Dual CARM1-and IKZF3-targeting: A novel approach to multiple myeloma therapy
|
Ni, Wei
|
|
|
33 |
1 |
p.
|
artikel
|
| 14 |
Enhancement of radio-sensitivity by inhibition of Janus kinase signaling with oclacitinib in canine tumor cell lines
|
Owaki, Ryo
|
|
|
33 |
1 |
p.
|
artikel
|
| 15 |
Enhancing NK cell-mediated tumor killing of B7-H6+ cells with bispecific antibodies targeting allosteric sites of NKp30
|
Fournier, Léxane
|
|
|
33 |
1 |
p.
|
artikel
|
| 16 |
Enhancing ovarian cancer treatment by synergistically targeting HER2 and PD-L1
|
Zhang, Shuo
|
|
|
33 |
1 |
p.
|
artikel
|
| 17 |
FOXJ3, a novel tumor suppressor in neuroblastoma
|
Challagundla, Kishore B.
|
|
|
33 |
1 |
p.
|
artikel
|
| 18 |
Immunity revealed: Stratifying hepatocellular carcinoma for precision immunotherapy
|
Arvanitakis, Konstantinos
|
|
|
33 |
1 |
p.
|
artikel
|
| 19 |
Insights into expression and localization of HPV16 LCR-associated transcription factors and association with LCR activity in HNSCC
|
Aggarwal, Nikita
|
|
|
33 |
1 |
p.
|
artikel
|
| 20 |
KPC pancreatic cancer cells are a novel immunocompetent murine model supporting human adenovirus replication and tumor oncolysis
|
Otero-Mateo, Marc
|
|
|
33 |
1 |
p.
|
artikel
|
| 21 |
Metabolites and metabolic pathway reactions links to sensitization of immunotherapy in pan-cancer
|
Yu, Shaobo
|
|
|
33 |
1 |
p.
|
artikel
|
| 22 |
miRNA-dependent resistance mechanisms to anti-hormonal therapies in estrogen receptor-positive breast cancer patients
|
Al Hashami, Zainab Salam
|
|
|
33 |
1 |
p.
|
artikel
|
| 23 |
Mission impossible: mesenchymal stem cells delivering oncolytic viruses before self-destruction
|
Li, Jia-Xu
|
|
|
33 |
1 |
p.
|
artikel
|
| 24 |
Mitigating IL-12-induced toxicities: A path forward with TNF inhibition
|
Davydova, Julia
|
|
|
33 |
1 |
p.
|
artikel
|
| 25 |
Oncolytic adenovirus inhibits TNBC tumor growth/metastasis in mice by targeting TGF-β and overexpressing GM-CSF
|
Nhàn, Nguyễn Thị Thanh
|
|
|
33 |
1 |
p.
|
artikel
|
| 26 |
Preclinical study of inetetamab combined with atezolizumab to synergistically inhibit HER2 and PD-L1 in the treatment of ovarian cancer
|
Ying, Feiquan
|
|
|
33 |
1 |
p.
|
artikel
|
| 27 |
Resistance signatures to oncolytic vesiculoviruses in pancreatic ductal adenocarcinoma
|
Watters, Chelsae R.
|
|
|
33 |
1 |
p.
|
artikel
|
| 28 |
Reversing regulatory safeguards: Targeting the ATR pathway to overcome PARP inhibitor resistance
|
Lin, Xixi
|
|
|
33 |
1 |
p.
|
artikel
|
| 29 |
Role of exosomes in diagnosis, prognostication, and treatment of pediatric solid tumors
|
Ghufran, Shaikh M.
|
|
|
33 |
1 |
p.
|
artikel
|
| 30 |
Ruxolitinib and oHSV combination therapy increases CD4 T cell activity and germinal center B cell populations in murine sarcoma
|
Dhital, Ravi
|
|
|
33 |
1 |
p.
|
artikel
|
| 31 |
SAP30, a novel autophagy regulatory gene in neuroblastoma
|
Pathania, Anup S.
|
|
|
33 |
1 |
p.
|
artikel
|
| 32 |
Structural insights and clinical advances in small-molecule inhibitors targeting TGF-β receptor I
|
Leonardo-Sousa, Carlota
|
|
|
33 |
1 |
p.
|
artikel
|
| 33 |
The 16th International Oncolytic Virus Conference: Advancing oncolytic virotherapy by balancing anti-tumor and anti-viral immunity
|
Stavrakaki, Eftychia
|
|
|
33 |
1 |
p.
|
artikel
|
| 34 |
Tumor-specific cytosol-penetrating antibodies for antigen- and TME-dependent intracellular cargo delivery
|
Dombrowsky, Carolin Sophie
|
|
|
33 |
1 |
p.
|
artikel
|
| 35 |
Unveiling the nexus: Oncolytic viruses, extracellular vesicles, and immune modulation
|
Cordelier, Pierre
|
|
|
33 |
1 |
p.
|
artikel
|
| 36 |
Use of patient-derived organotypic tumor spheroids for testing of viral vector gene therapy in combination with checkpoint blockade
|
Domingues, Ana Carolina M.
|
|
|
33 |
1 |
p.
|
artikel
|
| 37 |
What a model: A newly developed pancreatic murine cell line permissive to adenoviral replication
|
Fusciello, Manlio
|
|
|
33 |
1 |
p.
|
artikel
|
Tijdschrift beschrijving